Insider Transactions in Q3 2024 at Apogee Therapeutics, Inc. (APGE)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 04
2024
|
Michael Thomas Henderson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
40,000
-1.4%
|
$1,880,000
$47.75 P/Share
|
|
Sep 04
2024
|
Carl Dambkowski Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,665
-1.16%
|
$313,255
$47.78 P/Share
|
|
Aug 23
2024
|
Jane Henderson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,000
-2.9%
|
$288,000
$48.26 P/Share
|
|
Aug 07
2024
|
Michael Thomas Henderson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
40,000
-0.91%
|
$1,640,000
$41.36 P/Share
|
|
Aug 07
2024
|
Carl Dambkowski Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,335
-0.83%
|
$300,735
$41.37 P/Share
|
|
Jul 05
2024
|
Michael Thomas Henderson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,000
-1.01%
|
$555,000
$37.26 P/Share
|
|
Jul 03
2024
|
Carl Dambkowski Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,995
-1.0%
|
$221,815
$37.73 P/Share
|